Tim Sauer

Heidelberg University

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Haiyang Yun

Heidelberg University

GERMANY

View details

Navin Varadarajan

Professor

University of Houston

UNITED STATES

View details

Cliona M. Rooney

Baylor College of Medicine

UNITED STATES

View details

Linus Angenendt

University Hospital Münster

GERMANY

View details

dirk dittmer

Professor

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tim Sauer

Research Interests

Explore related searches

Contact this professor

Articles (10)

TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength

Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma

A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia

Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia

CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells

Inotuzumab Ozogamicin Induction Followed By Standard Chemotherapy Yields High Remission Rates and Promising Survival in Older (> 55 Years) Patients with De Novo B-Lymphoblastic Leukemia (GMALL-Initial1 Trial)

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

LigandCD70.CAR As a Platform for Dual-Targeting CAR T Cells for Acute Myeloid Leukemia

Macs - a Leukemic Stem Cell- Based Predictor of Clinical Response to Venetoclax and Other BH3 Mimetics for Acute Myeloid Leukemia

Collaborators (5)

Haiyang Yun

Navin Varadarajan

Cliona M. Rooney

Linus Angenendt

dirk dittmer

Make your next move.